API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://apnimed.com/apnimed-announces-positive-topline-results-for-mariposa-trial-of-ad109/
https://www.globenewswire.com/news-release/2021/11/17/2336301/0/en/OWP-Pharmaceuticals-Announces-IND-Authorization-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disorde.html
https://www.fiercebiotech.com/biotech/apnimed-sees-positives-midstage-data-for-its-attempt-at-drugging-sleep-apnea-problem
https://www.globenewswire.com/news-release/2021/04/22/2215011/0/en/OWP-Pharmaceuticals-Announces-Patent-Application-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disord.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090609
https://www.statnews.com/2017/08/16/eli-lilly-canada-patents-zyprexa-strattera/
http://www.fiercepharma.com/pharma/lilly-s-adhd-med-strattera-faces-new-generic-competition-from-teva-and-others
http://www.prnewswire.com/news-releases/fda-approves-first-generic-strattera-for-the-treatment-of-adhd-300465740.html
http://www.fiercepharma.com/pharma/generics-set-to-undercut-blockbusters-from-merck-novartis-bms-2017
http://www.fiercepharma.com/pharma/eli-lilly-targets-salesforce-for-job-cuts-wake-alzheimer-s-failure
http://www.pmlive.com/pharma_news/shire_launches_long-acting_adhd_drug_intuniv_in_uk_951910?
http://www.fiercepharma.com/story/lilly-falls-short-analyst-forecasts-2016-guidance-weaker-end/2016-01-05
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.thestar.com/news/canada/2015/03/30/health-canada-issues-stronger-clearer-warnings-about-suicide-risks-linked-to-adhd-drugs.html
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52759a-eng.php